BRYOSTATIN 1

Search structure
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Alzheimer Disease Phase 2 ClinicalTrials
Carcinoma, Renal Cell; Kidney Neoplasms Phase 2 ClinicalTrials
Alzheimer Disease Phase 1/Phase 2 ClinicalTrials
Hodgkin Disease Phase 2 ClinicalTrials
Head and Neck Neoplasms Phase 2 ClinicalTrials
Uterine Cervical Neoplasms Phase 2 ClinicalTrials
Prostatic Neoplasms Phase 2 ClinicalTrials
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Anemia; Anemia, Refractory; Blast Crisis; Hemoglobinuria; Hemoglobinuria, Paroxysmal; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelomonocytic, Juvenile; Myelodysplastic Syndromes; Thrombocytopenia Phase 1 ClinicalTrials
Adenocarcinoma; Carcinoma, Acinar Cell; Pancreatic Neoplasms Phase 2 ClinicalTrials
Carcinoma, Renal Cell; Kidney Neoplasms Phase 2 ClinicalTrials
Carcinoma, Renal Cell; Melanoma Phase 1 ClinicalTrials
Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms Phase 2 ClinicalTrials
Carcinoma, Renal Cell; Kidney Neoplasms; Melanoma Phase 1 ClinicalTrials
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin Phase 1 ClinicalTrials
Adenocarcinoma; Colorectal Neoplasms Phase 2 ClinicalTrials
Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin Phase 1 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Myelodysplastic Syndromes; Preleukemia; Syndrome Phase 2 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin Phase 2 ClinicalTrials
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell Phase 1 ClinicalTrials
Leukemia; Lymphoma; Lymphoma, Non-Hodgkin Phase 2 ClinicalTrials
Carcinoma, Renal Cell Phase 2 ClinicalTrials
Esophageal Neoplasms; Stomach Neoplasms Phase 2 ClinicalTrials
Leukemia; Lymphoma Phase 1 ClinicalTrials
Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Preleukemia; Syndrome Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell; Plasmacytoma Phase 2 ClinicalTrials
Leukemia Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Lymphoma; Lymphoma, Non-Hodgkin Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Intestinal Neoplasms; Lymphoma Phase 1 ClinicalTrials
Burkitt Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms, Plasma Cell; Plasmablastic Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase 1 ClinicalTrials
CONTENTS